Naloxone effects on serum growth hormone and prolactin in man
Authors:
- 1 January 1979
- journal article
- research article
- Published by Springer Nature in Psychopharmacology
- Vol. 65 (1) , 95-97
Abstract
Endogenous and exogenous opiate-like compounds have been found to cause increased serum growth hormone and prolactin levels in animals, and, in some cases, humans. Naloxone, a relatively specific narcotic antagonist, decreases serum prolactin and growth hormone levels in animals. Naloxone (20 mg IV) did not significantly alter serum prolactin levels and, minimally but not significantly, increased growth hormone levels in humans to whom it was administered.Keywords
This publication has 9 references indexed in Scilit:
- Effects of naloxone in normal, manic, and schizophrenic patients: evidence for alleviation of manic symptoms1979
- PROLACTIN SECRETION, A MEASURABLE CENTRAL EFFECT OF OPIATE-RECEPTOR ANTAGONISTSThe Lancet, 1978
- Enkephalin analogues and naloxone modulate the release of growth hormone and prolactin - evidence for regulation by an endogenous opioid peptide in brainLife Sciences, 1977
- Effects of naloxone, morphine and methionine enkephalin on serum prolactin, luteinizing hormone, follicle stimulating hormone, thyroid stimulating hormone and growth hormoneLife Sciences, 1977
- STIMULATION IN VIVO OF THE SECRETION OF PROLACTIN AND GROWTH HORMONE BY β-ENDORPHINEndocrinology, 1977
- Enkephalin-stimulated prolactin releaseLife Sciences, 1976
- EFFECTS OF MORPHINE ON SERUM GROWTH HORMONE, CORTISOL, PROLACTIN AND THYROID STIMULATING HORMONE IN MANThe Journal of Clinical Endocrinology & Metabolism, 1975
- Sleep-Related, Nyctohemeral and Briefly Episodic Variation in Human Plasma Prolactin ConcentrationsThe Journal of Clinical Endocrinology & Metabolism, 1973
- Human Growth Hormone Release During Sleep: Electroencephalographic Correlation1The Journal of Clinical Endocrinology & Metabolism, 1969